Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS₄₀ Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response

• Main Authors: Oleg V. Markov (Author), Aleksandra V. Sen'kova (Author), Islam S. Mohamed (Author), Elena V. Shmendel (Author), Mikhail A. Maslov (Author), Anastasiya L. Oshchepkova (Author), Evgeniy V. Brenner (Author), Nadezhda L. Mironova (Author), Marina A. Zenkova (Author)
• Format: Book
• Published: MDPI AG, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cell-free antitumor vaccines represent a promising approach to immunotherapy of cancer. Here, we compare the antitumor potential of cell-free vaccines based on microvesicles derived from dendritic cells (DCs) with DC- and cationic-liposome-based vaccines using a murine model of drug-resistant lympho...